GLOBUS MEDICAL, INC. Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31)
GLOBUS MEDICAL, INC. (GMED) had Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) of $7.36 million as of 2012-12-31, per its 10-K/A filed 2013-06-13.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionContingentConsiderationAtFairValue · last filed 2013-06-13
- 2012-12-31: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $7.36M.
- 2011-12-31: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $4.93M.
- 2010-12-31: Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) $0.00.
| Period end | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) |
|---|---|
| 2012-12-31 | $7.36M 10-K/A · filed 2013-06-13 |
| 2011-12-31 | $4.93M 10-K/A · filed 2013-06-13 |
| 2010-12-31 | $0.00 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |